COMP <GO>
MRK vs AZN // NET PROFIT MARGIN
Merck & Company Inc. (NYSE) VS. AstraZeneca PLC (NYSE) • 15-METRIC TALLY: MRK 10
— AZN 3
▲ NET PROFIT MARGIN LEADER: MRK
LAST: $146.33 (+3.83%) • MKT CAP: $361.02B
net-margins
28.10%
LAST: $174.40 (+2.89%) • MKT CAP: $270.45B
net-margins
10.90%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MRK VS. AZN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MRK | AZN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 74.80% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 20.70% | 9.90% | +10.80 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | 15.3x | 21.0x | -5.70 | MRK | /valuation <GO> |
| Free Cash Flow Yield | 3.42% | 2.21% | +1.21 | MRK | /fcf-yield <GO> |
| Operating Margin | 34.30% | 13.90% | +20.40 | MRK | /operating-margins <GO> |
| Net Profit Margin ACTIVE | 28.10% | 10.90% | +17.20 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | 1.30% | 22.00% | -20.70 | AZN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.26% | 0.00% | +2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.19 | 3.74 | +1.45 | MRK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | AZN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 51.7 | 56.8 | -5.10 | AZN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.92 | 0.91 | +0.01 | MRK | /macro-sensitivity <GO> |
| Forward P/E Multiple | 18.4x | 27.6x | -9.20 | MRK | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $361.02B | $270.45B | $90.57B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MRK REV | AZN REV | MRK GROSS % | AZN GROSS % | MRK FCF | AZN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $65.01B | — | 74.8% | — | $12.36B | — |
| FY 2024 | $64.17B | — | 76.3% | — | $18.10B | — |
| FY 2023 | $60.12B | — | — | — | $10.30B | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MRK // BETA 0.92
AZN // BETA 0.91